Policy & governance of innovative technologies

Regulations, standards and guidelines to ensure safety, quality and efficacy are an integral part of the development of technological advances, particularly in life sciences. Innogen’s research on the governance systems we adopt for innovative technologies, how such choices are made and their impact on future innovation trajectories, the fate of future sectors of the economy, and the competitive advantage of nations, is internationally unique.

Projects

Innogen contributes to TIBA initiatives

27 June 2019

Geoff Banda, Innogen co-Director and TIBA Work Package leader, has been involved in delivering an intellectual property workshop in Johannesburg and the development of the ‘Research for Health and Innovation Strategy for Africa’.

Innogen Research on Covid-19

27 March 2020

Recent publications by Innogen members draw attention to lessons learnt from previous outbreaks of infectious disease, and to the importance of ‘local health’ and the law in global health emergencies.

PAS 440 — Responsible Innovation in the spotlight

15 December 2020

In the latest episode of the BSI EDUCATION PODCAST, Joyce Tait, technical author of the standard PAS 440 explains how it was developed and its relevance for regulatory adaptation in the UK.

Better politics for biotechnological innovations

9 September 2021

In a Commentary piece published in Transgenic Research, Alan Raybould, Innogen member and Chair in Innovation in the Life Sciences at the University of Edinburgh, argues that political leaders need to make a stronger case for green biotechnology in achieving food security and other sustainable development goals.

In Conversation event: Unlocking genetic technologies for agriculture

10 March 2022

On the 23rd of February, Peter Kearns, Special Advisor to Re-Imagine Europa, Joyce Tait, and Alan Raybould discussed the current regulation of genetic technologies for agriculture in the UK, Europe and the rest of the world.